Back to Search Start Over

SEVTAR—A multicenter randomized controlled trial to investigate the impact of prophylactic endoluminal placed vacuum sponge for prevention of anastomotic leakage after low rectal resections

Authors :
Leif Schiffmann
Matthias Becker
Leendert Develing
David Varga-Szabo
Caroline Scheidereiter-Krüger
Hubert Zirngibl
Michael Seifert
Lothar Biermann
Claudia Schlüter
Felicitas Tumczak
Arved Weimann
Boris Jansen-Winkeln
Ingo Wallstabe
Frank Schwandner
Sandra Denecke
Clemens Schafmayer
Imad Kamaleddine
Albrecht Stier
Katharina Haegele
Michael Kindler
Sabine Michling
Ernst-Wilhelm Horling
Ulrike Denzer
Source :
Frontiers in Surgery, Vol 9 (2023)
Publication Year :
2023
Publisher :
Frontiers Media S.A., 2023.

Abstract

BackgroundLow anterior resection for rectal cancer is commonly associated with a diverting stoma. In general, the stoma is closed 3 months after the initial operation. The diverting stoma reduces the rate of anastomotic leakage as well as the severeness of a potential leakage itself. Nevertheless, anastomotic leakage is still a life-threatening complication and might reduce the quality of life in the short and long term. In case of leakage, the construction can be converted into a Hartmann situation or it could be treated by endoscopic vacuum therapy or by leaving the drains. In recent years, endoscopic vacuum therapy has become the treatment of choice in many institutions. In this study, the hypothesis is to be evaluated, if a prophylactic endoscopic vacuum therapy reduces the rate of anastomotic leakage after rectal resections.MethodsA multicenter parallel group randomized controlled trial is planned in as many as possible centers in Europe. The study aims to recruit 362 analyzable patients with a resection of the rectum combined with a diverting ileostoma. The anastomosis has to be between 2 and 8 cm off the anal verge. Half of these patients receive a sponge for 5 days, and the control group is treated as usual in the participating hospitals. There will be a check for anastomotic leakage after 30 days. Primary end point is the rate of anastomotic leakages. The study will have 60% power to detect a difference of 10%, at a one-sided alpha significance level of 5%, assuming an anastomosis leakage rate of 10%–15%.DiscussionIf the hypothesis proves to be true, anastomosis leakage could be reduced significantly by placing a vacuum sponge over the anastomosis for 5 days.Trial registrationThe trial is registered at DRKS: DRKS00023436. It has been accredited by Onkocert of the German Society of Cancer: ST-D483. The leading Ethics Committee is the Ethics Committee of Rostock University with the registration ID A 2019–0203.

Details

Language :
English
ISSN :
2296875X
Volume :
9
Database :
Directory of Open Access Journals
Journal :
Frontiers in Surgery
Publication Type :
Academic Journal
Accession number :
edsdoj.fa2b55ef083f4bb6ba94103d706fb425
Document Type :
article
Full Text :
https://doi.org/10.3389/fsurg.2022.1099549